English
Specials
Upgrade

Moneycontrol

Budget 2023Budget 2023
Get App Open
In App
Open App

LIVE COVERAGE AND VIDEO PARTNERS

Lenovo Tech Today India Prestige Group
you are here:
Success
Alert
Please select a Day.
Info
Open Trading Account

Ganga Pharmaceuticals Ltd.

Sector: Pharmaceuticals
Add to
12.55
0.00 (0.00%)

As on 05 Jan, 2023 | 04:00

Day Range
12.55
15.30
L H
52 Week Range
5.00
16.57
L H
Volume
16,000
*
i

* BSE Market Depth (05 Jan 2023)

BUY SELL
QTY PRICE PRICE QTY
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on standalone numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on standalone numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on standalone numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on standalone numbers.
Powered by Powered by Trendlyne
MC Essentials
64% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Stock not eligible for rating

Financials
    Ownerships
      Industry Comparison
        Others
          Powered by Powered by Trendlyne
          Open 0.00
          Previous Close 0.00
          Volume 0.00
          Value (Lacs) 0.00
          i  VWAP 0.00
          Beta
          High 0.00
          Low 0.00
          UC Limit 0.00
          LC Limit 0.00
          52 Week High 0.00
          52 Week Low 0.00
          TTM EPS See historical trend 0.00
          TTM PE See historical trend --
          P/B See historical trend --
          Face Value 0.00
          Mkt Cap (Rs. Cr.) 0
          Dividend Yield --
          20D Avg Volume 0
          20D Avg Delivery(%) --
          Sector PE 0.00
          Book Value Per Share --

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          MC Insights

          Stock not eligible for rating

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 15.93% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Low in industry

          Shareholding Pattern
          • Promoters holding remains unchanged at 66.71% in Sep 2022 qtr
          Powered by Powered by Trendlyne

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Historical Prices
          Volume Analysis

          News

          Ganga Pharma: Outcome of AGM

          Ganga Pharma: Outcome of AGM

          Jul 27 2017 12:07 PM

          ₹ Earning

          Forum

          Community Sentiments

          Data not Available

          What's your call on today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          15 Feb, 2022

          NIRANJAN KUMAR GOEL

          Qty 32000 Price 15.37 % Traded 0.79
          14 Feb, 2022

          NIRANJAN KUMAR GOEL

          Qty 24000 Price 16.05 % Traded 0.59
          28 Jan, 2022

          BABALBHAI MANILAL PATEL

          Qty 24000 Price 11.01 % Traded 0.59
          25 Jan, 2022

          MUNEESH KAPOOR

          Qty 24000 Price 11.42 % Traded 0.59
          25 Jan, 2022

          BABALBHAI MANILAL PATEL

          Qty 24000 Price 11.42 % Traded 0.59
          16 Mar, 2020

          SHWETA AKASH SHARMA

          Qty 32000 Price 7.05 % Traded 0.79
          16 Mar, 2020

          KIRAN AMARNATH SHARMA

          Qty 24000 Price 7.05 % Traded 0.59
          16 Mar, 2020

          ARYAMAN BROKING LIMITED

          Qty 56000 Price 7.05 % Traded 1.38

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          + Show More
          Powered by Powered by Trendlyne

          Insider Transaction Summary

          No Data For Insider Transaction Summary.

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          25 Oct, 2016

          Aryaman Capital Markets Ltd Acquisition

          Other
          Qty 16000 Price 0 % Traded 0.39 Post Tnx Hold. 5.12%
          25 Aug, 2016

          Aryaman Capital Markets Ltd Disposal

          Other
          Qty 8000 Price 0 % Traded 0.19 Post Tnx Hold. 4.93%
          09 Aug, 2016

          Aryaman Capital Markets Ltd Acquisition

          Other
          Qty 8000 Price 0 % Traded 0.20 Post Tnx Hold. 5.12%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Corporate Action

          • No Data For Announcement.
          + See More
          Date Agenda
          + See More
          Ex-Date Type Dividend (Rs)
          + See More
          Announcement Date Ex-Bonus Ratio
          + See More
          Ex-Split Old FV New FV
          + See More
          Ex-Right Ratio Premium
          + See More
          Date Agenda
          + See More

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend
          Insights

          No Data For Institutional Holder Analysis.

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Ganga Pharma 12.55 - 5.10 - 0.94 0.70 - 0 2 0.33
          Suyog Gurbaxani 49.45 - 122.94 - 12.46 -70.22 6.34 -6 8 6.88
          Lucent Ind. 35.85 - 53.78 - 3.69 -0.41 - 0 0 0.26
          Gateway Dist-RE 14.00 - 22.53 - - -0.41 - 0 0 0.26
          Net Pix 35.00 - 11.20 - 1.90 -4.06 9.38 0 0 0.09
          + See More

          About the Company

          Ganga Pharmaceuticals Ltd. is a pharmaceutical company. It engaged in manufacturing of ayurvedic products, herbal tablets pills, balms, creams, syrups and oils.
          {"success":1,"data":{"address":{"address1":"Gangatat,Dhanvantary Marg,","address2":"GopcharPada,Virar (East),,","city":"Palghar","state":"Maharashtra","pincode":"401305","telephone1":"0250-6098333","telephone2":"0250-6098444","fax1":"0250-","fax2":"","email":"ayurvedganga@gmail.com","web":"http:\/\/www.ayurvedganga.com"},"management":[{"name":"Sanjay Vyankatesh Kulkarni","designation":"Chairman & Non-Exe.Director"},{"name":"Bharat Brijmohan Sharma","designation":"Managing Director & CEO"},{"name":"Srijna Bharat Sharma","designation":"Whole Time Director"},{"name":"Sachin Chandrakant Chavan","designation":"Independent Director"},{"name":"Chetan Bhikhubhai Patel","designation":"Independent Director"}],"registrars":{"name":"KFIN Technologies Pvt. Ltd.","address1":"Selenium Tower B, Plot No. 31-32,","address2":"Gachibowli, Financial District, \nNanakramguda,Seri","address3":"","address4":"","telephone":"040-67161500, 67162222, 33211000","fax":"040-23420814, 23001153","email":"einward.ris@karvy.com","internet":"http:\/\/www.kfintech.com","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"}],"details":{"bseId":"539680","nseId":"","series":"","isinid":"INE615T01017"}}}

          • Registered Office

          • Registrars

            • Address

              Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-67161500, 67162222, 33211000

            • Fax No.

              040-23420814, 23001153

            • Email

              einward.ris@karvy.com

            • Internet

              http://www.kfintech.com

          • Management

            • Sanjay Vyankatesh Kulkarni

              Chairman & Non-Exe.Director

            • Bharat Brijmohan Sharma

              Managing Director & CEO

            • Srijna Bharat Sharma

              Whole Time Director

            • Sachin Chandrakant Chavan

              Independent Director

            • Chetan Bhikhubhai Patel

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

          • Details

            • BSE:

              539680

            • NSE:

            • Series

            • ISIN

              INE615T01017

          Go to Top

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>